Charfty rnglstratlon number 109094
Company reg18trallon numbor N1685604 (Northern Ireland
PULMONARY FIBROSIS NI
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

PULMONARY FIBROSIS NI
LEGAL AND ADMINISTRATIVE INFORMATION
Trustees
T J Mcmillan
JMByme
M U Mcmillan
P M Gorman
I Simpson
Dr. N Chaudhuri
C J Donohoe
Charlty n￿rn￿r
109094
Company numb$r
N1685604
Registored offlce
3 Churthfield Road
Baltycastle
Northern Ireland
8T54 6PJ
Independent examlner
MTS Prior Mcmahon
clo Ards Business Hub
Sketrick House
Jubilee Road
Newtownards
Co Down
8T23 4YH

PULMONARY FIBROSIS NI
CONTENTS
Page
Trustees, report
Independent examinerfs report
Statement of financial activities
Balan￿ sheet
Notss to the financial statements
8-16

PULMONARY FIBROSIS NI
TRUSTEES, REPORT (INCLUDING DIRECTORS, REPORT)
FOR THE YEAR ENDED 28 FEBRUARY 2025
The Irustees present their annual report and financial statemenls for the year ended 28 February 2025.
The financial statements have been prepared in accordance the ac¢ounting policies set out In note I to the
ffinancial statements and compty wth the charity's Artides ofAs$o¢iation, the Companies Act 2006 and Accounting
and Reporting by Charities.. Statement of Recommended Practice applicable to charities preparing their accounts in
8ccordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 102}"
(effective 1 January 20191.
Constitution & Purpose
Pulmonary Fibrosis Nl (PFNI) is a charity governed by the Artides of Association & recognised as a Private
Limited Company by guarantee wthoul share capital use of 'Limited' by Companies House. incorporated 8
February 2022, Company No. N1685604, Charity NuM￿r 109094.
It is managed by the truste6s. Trustees are appointed by invitation & agreement of the Truste8s at the AGM or an
Extraordinary General Meeting. Trustees may hold office for a maximum of 2 years before r￿ppoIntrnent is
required unless they resign or are removed from office by a resolution of the other trustees at the AGM or an
Extraordinary General Meeting.
PFNI primarily seeks to benefit the Northern Ireland Gommunity through its activities which aim to prowde support
and relief for peopEe living with Pulmonary Fibiosis and other Interstibal Lung Diseases in Northern Ireland and to
advance education about Pulmonary Fibrosis and other InteTstits"al Lung Diseases.
Publlc Benefit
The public beneffts that flow from this purpose aFe to".
foster an atmosphere of mutual support and encouragement among people suffering from PLElmonary
Fibrosis and other Interstslial Lung Diseases IPF} and their carers. family and friends,.
raise awaroness for the benefit of the public about the effects of Pulmonary Fibrosis and other Interstitial
Lung Diseases and methods of management of such disease-
raise awareness for the ￿neffit of the public about the effects of Pulmonary Fibrosis and other Interstitial
Lung Diseases and methods of management of suth disease.,
promote and raise awareness of the Organ Donor Register for the benefit of the public.
The benefieiar*s of this pu¥pose are people living in Northem Ireland who have been diagnosed with
pulmonary fibrosis and other intefstitial lung diseases, their families, friends, colleagues, and the general public
at large.
Th8 direct benefits flowtng from this purpose include improved mental health and reduced levels of stress and
anxiety eXperIen￿d by our beneficiaries & an increase in their knowledge of how to live well with their condition.
These benefits are evidenced through tsedback from beneficiaries at appropriate intervals. A private benefit
flowing from this purpose 1$ the experience and knowledge members re￿1Ve. Howevei, this is incidental and
ne￿SSary as it 1$ essential lo ensure the benefit Is prowded to our beneficiaries. A privale benefit 1$ also gained
by SLtppliers who receive payments for goods and serVi￿S provided. The benefit is incidental and ne￿8$ary to
ensure that benefrt 15 provided to our beneficiaries. Any expenses paid lo Trustee$ 1$ reimbursemerrt for
expenses necessarily incurred in pursuit of the aims of the charity or of purchases made on behalf of the charity.

PULMONARY FIBROSIS NI
TRUSTEES. REPORT (INCLUDING DIRECTORS, REPORTI (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUAR Y 2025
The purposes of our charity may lead to the following risks..
a. Trips and falls when beneficiaries are using..
Puffin Lodge lour respite caravan}. This facility is unsuitable for people who use wheelchairs or
mobility 5COOters or who are unable to negotiate stairs. Site limitatr"on$ are highlighted lo applicant5
and mobility is assessed during the application pr￿$$.
Events venue$. Venues etc are assessed and chosen to ensure that the majority of our benefiaaries
can attend & use s8fety and comfortably.
b. Some ben&fiaari8s require oxygen1021 which can be deliVe￿d lo Puffin Lodge by BOC Ltd. The risks lo
beneficiaries assoaated with 02 include..
non-delivery by BOC {note.' limely ordering of 02 for delivery to & use at Puffin Lodge 1$ the
responsibilty of the beneficiary & they will contact BOC if this occurs}',
The equipment required to meet tho 02 requirements of the beneficiary would generate noise
levels that a￿ 8￿ptable to other site users.
Oxygen needs are discussed wrth the applicant and assessed during the application process. Unfortunately PLffin
Lodge, due to its location and construction, cannot facilitate the needs of all our bgngficiaries.
02 needs of beneficiaries are considered when Ofganising events to ensure, as far as reasonably
practicable, that the majority of beneficiaries can attend.
The potential of any such ham) or risk arising is outweighed by the benefit provided to the public.
The trustees have paid due regafd to guidance issued by the Charity Commission in deciding what activittes the
charity should undertake.

PULMONARY FIBROSIS NI
TRUSTEES, REPORT (INCLUDING DIRECTORS, REPORT) (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
Revlew of Publlc B•n•fit Activlties in 2024125
PFNI conb'nued to develop their activities to rea¢h and $&rve people with Pulmonary Fibrosis IPF), their Ca￿r$ and
families, and increase awareness of PF within the eommunfy at large.
Ini3 Ceithleann, Ouf respite home in Enniskillen was purchased in July 2024. Throughout the year Puffin Lodge. our
Ballycastle respite gnd Inis Ceithleann were well used by families to have 4 much needed break from home. They
also hosted fundraising coffee mornings & open days for member to view the facilities available lo them.
Further publi¢ benefft activtties induded..
Continued production of a comprehensive infomats'on pack that clinicians give to their patients on
diagnosis or can be requested trom PFNI directly. These were developed in collaboration with specialist PF
clinician5.
b. week￿ Zoom meeting were held for PF patients & monthty meeting for carefs. Speakers from the Health
Boards, Nl Hospice and other guest speakers were invited to talk to attendees about issues relevant lo
them induding dealing with fatigue, nutrition, dealing with stress & anxiety, and the ever popular relaxation
tsster session.
The number ofAmbassadors increased during the year under the guidan￿ of an Ambassador Co-ordinator
(Twstee). Ambassadors liaise with and assist beneficiaries in their local area_
d. Pur¢hase of hand-held fans for distribution to PF patients by dinicians.
Introduction of the 'Pete & Tilty Club. Pfoviding support lo bereaved famity members including beteaved
adult ¢hildren. Support includes on-line support group, wellbeing tripslmeet-ups etc
A Befriending seNce was intr¢XlU￿d & volunteers we trained in the role.
g. Sponsoring t￿0 PF medical research $tudenships in partnership with Queen's University, Belfast.
h. In June 2024 Pete The Pufflings Brave Adventure chiklren's book was launched. The book aims lo
introduce Pulmonary Fibrosis to children and open discussion in families. It has bean extremely well
received.
Education
We attended numerous events where we were able lo provide infomiation to the public about Pulmonary Fibrosis
and PFNI. These ranged from fundraising events to specialist conferences.
Our website is extensive and regularly updated. We aim to support and supplement infomiation provided by
clinicians about PF and ensure that all infomalion Pfovided is accurate and current by liaising with medical
professionals.
Flnanelal r•vlow
Annual Incom
During the year the Charity generated incoming resources of £215.003.
All incomes were derived from personal or business donations, fundraising ath"vities by our beneficiaries &
supporters, and grants.
Annua
enditure
Financialty 2024125 was a satisfactory year for PFNI. Apart from costs associated with administration of the charity
all expendtture was in th¢ furtherance of the aims of the charity- All volunteers are entitled to receive out-Of￿0Ckel
expenses. All volunteers are entitled to receive travel expenses for joumeys on official business which are paid at a
standard rate accepted by HMRC as giving no personal gain to th8 reopient
Outgoing Tesources were £73,577 leaving net incoming resources of £141,426 for the year to 31 March 2025.

PULMONARY FIBROSIS NI
TRUSTEES, REPORT (INCLUDING DIRECTORS. REPORT) {CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
Charity resarv&s should provide the organisation with adequate financial stability and the means for it to meet its
charitable objectives for the foreseeable fijture.
The Trustees retain funds in the Charity to fi'nance the ongoing running costs of the ¢harity and to provide fvnds at
short notice to finance the obj'ectives of the chanty.
Plans for future perlods
The Trustees of PFNI plan to..
Encourage the use of both respite properties by those living with PF to enjoy so rest and relaxation.
To contrnue to build strong relation5hip5 Wlth medical professionals.
To Continue to build relalionships with local. national and international communities. businesses & charities
to improve and increase awareness & knowled9e of PF & PFNI.
k. To provKle events and activities to benefit the knowledge, mental health and wellbein9 of our beneficiaries.
To identify areas where we can provide support for family members of PF patsents, including chiklren.
Structur8, govgrnance and management
The trustees, who are a150 the direrlors for the PUTpose of company law. and who served during the year and up to
the date of signature of the finanaal statemBnts were..
T J Mcmillan
JMByme
M U Mcmillan
P M Gomian
I Simpson
Dr. N Chaudhuri
C J Donohoe
The trustees, report was approved by the Board of Trustees.
Juuitli Byme INOV 26, 2
JMByme
Tntstee
-5 18.4fJ.'44 CIITI
26 November 2025

PULMONARY FIBROSIS NI
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF PULMONARY FIBROSIS NI
I report to the Irust•8s on my examination of the financial statements of Pulmonary Fibrosis Nl Ilho charity) for the
year ended 28 February 2025.
Rosponsibiliti•s and basls of report
As the trustees of the charity land also its directors for the purposes of ¢ompany law) you ar6 r8spon5ible for the
preparation of the financÉal stslements in ac¢ordan¢e with the requirements of th8 Companies Act 20Ce (the 2006
Act).
HavFng satisfied myself that the charity is not subject to audit under company law, and is eligible for independent
examination, it is my Yesponsibilty to..
examine the a¢￿Unts under section 65 of the Charities Act
follow the piocedure5 laid down in the general Directions given by the Charity Commission for Northem
Ireland under section 65{9llbl of the Charitses Act
state whether paiticular matters have come lo my attention.
Independent oxaminerfs statement
I have examined your charity accounts as required under section 65 of the Charitses Act and my examination was
Caf¥sed out in accordance wilh the general Directions given by the Charity Commission for Northem Ireland under
section 6519Mb) of the Charities Act. The examination included a review of the ac¢ounb'ng record5 kept by the
charity and a comparison of the accounts Presented with those re<x>rds. It also induded consideration of any
unusual items or disc&)sures in the accounts, and seeking exKAanations from you as charity trustees corsceming any
such matters. I confirm that no matters have come to my attention in connection with the examination giving me
cause to believe Ihat in any material respect..
accounting records were not kept in respect of the charity as required by section 386 of the 2006 A¢t', or
the financial statements do not a￿ord wth those records". or
the financTral statements do not comply with the accounting requirements of section 396 of the 2006 Act other
than any requirement that the accounts give a true and fair view whi¢h 1$ not a matt•r ¢onsid¢red as part of an
independent examination,. or
the financial statements have not been prepared in accordan￿ wth the methods and principles of the
Statement of Recommended Practi￿ for accounting and reporting by ¢haritios applicable to charities
preparing their accounts in accordan￿ wilh the Financial Reporting Standard applicable in the UK and
Republic of Ireland (FRS 102).
I have no concerns and have come across no other matter5 in connection w4th the examination to which attenbon
should be drawn in this report in order to enable a proper understanding of the financial statemonts to be reached.
Paula
rmstron
P31113 Ariiisrrong i1Sov 27, 2Q25 D7..2f)'.28 G&ITi
Paula AmstrorvJ
For and on behalf ot MTS Prlor Mcmahon
Chartorod A¢countants
clo Ard$ Business Hub
Sketrick House
Jubilee Road
Newlownards
Co Down
BT23 4YH
Dated: 26 November 2025

PULMONARY FIBROSIS NI
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 28 FEBRUAR Y 2025
Unrestricted Resfficted
funds
funds
202S
2025
Total Unr•8trl¢t•d Ro$trl¢ted
fund$
funds
2024
Total
2025
2024
2024
Notes
Incomg from:
Donations and legaaes
Charitable activities
Other activities
Investments
92,807
7,407
41,202
3,587
70,000
182,807
7,407
41,202
3,587
67,802
129,260
197,062
82,466
82,466
Totsl incomg
145.003
70,000
215,003
150,268
129,260
279,528
Expendlture on:
Raising funds
Charitable acbvities
1,791
71,786
1,791
71,786
2,500
27,645
27,645
Total gxp¢ndituro
73,577
73,577
30,145
30,145
Net incomè and movemgnt in
fund$
71,426
70,000
141.426
120,123
129,260
249.383
Reconciliatlon of fvnds:
Fund balances at 1 MarL* 2024
221,746
129,260
351,OC
101,623
101,623
Fund balances at 28 February
2025
293,172
199.260
492,432
221,746
129,260
351,OC
The statement of finanaal activities includes all gains and Ioss8s recognised in the year. All income and expenditu
derive from continuing acttrvities.

PULMONARY FIBROSIS NI
BALANCE SHEET
AS AT 28 FEBRUARY2025
2026
2024
Notes
Flxed assets
Tangib￿ assets
14
378,856
57,247
Current •880ts
Debtors
Cash at bank and in hand
16
9,420
105,776
2,000
292,539
115,196
294.539
Creditors- amounts falling due within
ono yoor
16
11,620}
{780)
Net current as$ets
113,576
293,759
Total assets les$ CUTrent liabilities
492,432
351.006
Net assets excluding pension liability
492.432
351,006
The funds of the charity
Restricted income funds
Unrestrlcted lunds
17
199.260
293.172
129,26Q
221,746
492,432
351,006
The company is entitled to the exemption from the audit requirement eontained in section 477 of the Companies Act
2006, for the year ended 28 February 2025.
The directors acknowledge their responsibilities for complying with the requiTemen15 of the Companies Act 2006
with respect to accounting records and the preparation of finanoal statements.
The members have not required the company lo obtain an audit of its financial stslements for the year in question in
accordance with section 476.
These financial statements have been prepared in a¢cordan¢e with the provisions applicablo to wmpanies subject
to the small companies regime.
The financial statements were approved by the trustees on 26 November 2025
15'.49..**GMTI
J M Byrne
Trusteo
Company registration number N1685604 {Nothem Ireland)

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
A¢¢ountlng pollcl68
Charfty Infonnatlon
Pulmonary Fibrosis Nl is a private company limited by guarantee incorporated in Northern Ireland. The
registered office is 3 Churchfield Road, Balty¢astle, BT54 6PJ, Northern Ireland.
1.1 A¢countlng conventlon
The )Inancial statements have been prepared in accordan￿ with the charity's Igoveming documenti, the
Companies Act 2006, FRS 102 "The Financial Repo￿"ng Stsndard applicable in the UK and Republic of
Ireland" I'FRS 102") and the Charities SORP "Accounting and Reporting by Charities.. Statement of
Recommended Pra¢tice op￿1¢al￿e to charities preparing their accounts in accordan￿ with the FiTran¢ial
Reporting Standard applicable in the UK and Republic of Ireland (FRS 1021" (effective 1 January 2019). The
Charity is a Public Benefit Entity as defined by FRS 102.
The charity has taken advantage of the provisions in the SORP for charities not to prepaTQ a Statement of
Cash Flows.
The financial statements are prepared in sterling, whi¢h is the fvnctional currency of the charity. Monetary
amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the hi$tOTÉcal cost convention, Imodified to indude the
revaluatson of freehokl properties and to include investrnent properties and ￿rtain financial instruments at fair
valuel. The principal accounting policies adopted are set out below.
1.2 Going con¢ern
At the time of approving the financial statements. the trustees have a reasonable expectation that the charity
has adequate resources to continue in operational existen￿ for the foreseeable fvture. Thus the trustees
)ntinue to adopt the going cOn￿M basis of accounting in preparing the financial slatemants,
1.3 Charltable funds
Unrestricted fvnds are available for use at the discretson of the trustees in furtherance of their charitable
objectives.
Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The
pijrposes and uses of the restiicted fvnds are set out in the notes to the financi81 statements.
Endowment funds are subject to specific conditsons by donors that the capital musl be maintained by the
charsty.
1.4 Income
Income is f8cognised when the charity is legally entitled to it after any perfomiance conditlOn5 have b8en met.
the amounts can be measured reliably, and it is probable thal income will be received.
Cash donations are recognised on receipt. other donations are recognised once the charity has been notified
of the donab'on, unless perfomiance conditions require deferral of the amount. Income tax recovemble in
relation to donations re￿iVed under Gift Aid or deed$ of covenant 1$ recognised at Ihe time of the donation.
Legacies are recognised on receipt or othe￿is8 if the charity has been notified of an impending dislributson,
the amount 1$ known, and receipt 15 expected. If the amount is not known, the legacy is treated a$ a
conb'ngent asset.

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
Accountlng poll¢loS
(Contlnu•dl
1.6 Expendlture
Expenditure is ￿COgnISed On￿ there is a legal or constructive obligation to tr8nsfer economic benefit to a
third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of
the obligation can be measured reliabty.
ExpenditL*re is classified by acÈivity. The costs of each activity are made up of the total of direct costs and
shared costs. including support Costs involved in Lindertaking each activity. Direct costs attributable to a single
activity are allocated direcNy lo that activty. ShaTed costs which contribltle to moTe than one activty and
support costs which are not attributable to a single activity are apportioned be￿een those activities on a basis
Consistent WFth the use of resources. CerÈtral staff costs are allocated oft the basis of time spent, and
depreciation charges are allorated on the portion of the asset's use.
1.6 Tanglble Ilxed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of
depreciation and any impaimient losses.
Depreciabon is recogni5￿￿ so as to write off the cost or valuation of assets less their residual values over their
usefvl lives on the ft)Ilowing bases..
Inis Coith￿ann House, Enniskillen
Puffin Lodge Caravan. Ballycastle
Fixtures afKI ftttings
CompLrtors
2¥. Strdight Line
10% Redu¢ing balance
20% Reducing balance
25% Straight line
The gain or loss arisiny on the disposal of an asset is deteThined as the difference betsveen the sale proceeds
and the carrying value of tho a$get, and is rgcognised in the statement of financial activities.
1.7 Impalrment of flxod assets
At each reporting end date. the tharity reviews the carrying amounts of its tangible assets to determine
whether the￿ is any indicab.on that those assets have suffered an impairment loss. If any suth indication
exists. the recoverable amount of the asset is estimated in order to detemine the extent of the impairment
loss lif any).
1.8 Cash and cash equlvalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-temi liquid
investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown
within borrowings in current liabilities.
1.9 Flnancial ingtrurngnts
The charty has elected to apply the provisions of Section 11 'Bagic Fingncial Inslrumenl$' and Section 12
'Other Financial Instruments Issues, of FRS 102 to all of its financial instrLtments.
Financial instruments are recognised in the chafity's balan￿ Sheet when the Gharity becomes paty to the
contractual provisions of the instrument.
Financial assets and liabilities are offset, with Ihe net amounts presented in the financial statements. when
there is a legally enforceable right lo set off the recognised amounts and there is an intention to settle on a net
basis or to realise the asset and settle the liability simultaneously.

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUAR Y 2025
A¢¢ountlng policies
(Contlnuod)
8asl¢ flnanclal assets
Basic financial assets, which include debtors and ca$h and bank balancBs. are initially measured at
transacts.on price including transaction ¢osts and are 5ubsequenUy carried at amortised cost using the effective
interest method untess the arrangemer)I constitutes a financing transaction, wheie the transaction is
measured at the present value of the fvtU￿ receipts discounted at a market rate of interest. Financial assets
classified as receivable within one year are not amortised.
Baslc ffnan¢lal Ilabllftlos
Basic finan¢ial liabilities. including creditors and bank loans are initially recognised at transaction price unless
the arTangement ￿nstitUteS a financing transaction, where the debt iristrument is measured at the present
value of the future payments discounted at a market rate of interest. Financial liabilitie5 da55ified as payable
Wtthin one year are not amortised.
Debt instruments are Subsequently carried 8t amorkn"5ed c05t, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been ac4uired in the ordinary course of
o￿TatiOnS from suppliers. Amounts payable are classified a5 current liabilities if payment is due within one
year or less. If not, they are presented as non-current liabilities. Trade cr￿litorS are recognised inib.ally at
transaction price and $ubgequently measured at amortised cost using the effective interegt method.
Derecognitlon of flnanclal Ilablllties
Financial Iiabililtes are derecognised when the charity's contractual obligations expire or are discharged or
cancelled.
1.10 Ernployeg beneflts
The cost of any unused holKJay entitlement is recognised in the period in which th8 employee's services ale
received.
Temiination benefits are ￿cOgnised immediately as an expense when the charity is demonstrably Committed
lo tsmiinate the employment of an employee or to provide teThination benefits.
Crltlcal accountlng esdmates and Judggmgnts
In the applicatson of the charity's accountsng policies. the trustees are requirod to make judgements, esttmates
af¥J assumptions about the carrying amount of assets and liabilities that are not readily apparent from olhef
SoUr￿s. The estimates and associated assumptions are based on historical experience and other fadors that
are constdered to be ￿leVant. Actual results may differ from these estimates.
The estimates and undertying assumptions are reviewed on an ongoing basis. Revisions to accounting
estimates are ￿COgniSed in the period in which the estimate is remsed where the revision affect5 only that
period, OT in the period of the revision and ftrture period$ where the revision affects both current and future
periods.
10-

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS ICONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY2025
Income from donations and legacles
Unre8trlcted R•$trfeted
funds
funds
2025
2025
Totsl Unrestrlcted Re8trlcted
funds
funds
2024
2024
Total
2025
2024
Donations and gifts
Grants Received
Contributions from Puffin
Lodge
Contributions from Inis
Ceithleann
86,010
86,010
70,000
67,802
129,260
197.OS2
70,000
3,352
3.352
3.445
3,445
92,807
70,000
162.807
67.802
129,260
f97,062
Income from charttable actlvltles
Unr￿trIcted
fund¥
2025
Unrestricted
funds
2024
Sale of books & merchandise
7,407
Income from other a¢tivitle¥
Unr08tr1et•d Unrgstrlcted
funds
funds
2025
2024
Fundraising events
41,202
82,466
Income from Investments
Unrestricted Unr¢$trlctsd
funds
funds
2025
2024
Interest received
3,587
11

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY2025
Expendi￿re on ralslng funds
Unrestrlcted Unrestrlctèd
funds
funds
2025
2024
FundraisSng and publi¢lty
Advertising
Support costs
337
1,454
2,500
1,791
2,500
Expenditure on charltable activltso8
Unrestrlcted Unrestrletsd
Fund8
Funds
2025
2024
Dlrect costs
Depreciation and impaimient
Insurance
Puffin lodge costs
General expenses
Postage
Computer & website costs
Telephone
Printing
Travel & Accommodation
Member Gift$ & Services
Research Sponsorship
Inis Ceithleann House costs
Subscriptions
11,253
1.244
7,047
120
259
3.286
311
2.751
2,955
5,640
4,500
27,113
1,033
7,341
897
7,195
707
191
918
90
2,608
2,200
3,885
67,512
26,032
Share of support and governance costs (see note 91
Govemance
4,274
1,613
71,786
27,645
Analysls by fund
Unrestricted fvnds
71,786
27,645
12-

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY2025
Support ¢osts alloeated to actlviti&s
2025
2024
Fundraising
Govemance c08ts
2,500
1,613
4,274
5.728
4.113
Analysed betr•een:
Fundraising
Professional Fees
1,454
4.274
2,500
1,613
5,728
4.113
10 Nel movement In funds
202S
2Q24
The net movement in funds is ststed after chalginglluediting)".
Depreciab"on of owned tangible fixed asset$
11,253
7,341
11 Trusteès
None of the trustees lor any pefSOnS connected with them) r￿1ved any remuneration or benefits from the
chartty dufing the year.
12 Employees
The average monthty number of employees during the year was..
2025
Number
2024
Number
Total
There were no employees whose annual r8muneration was more than £60.000.
Remuneratlon of key managem•nt peTSonnel
The remunerats'on of key managemerkt personnel was as follows..
13 T•xation
The charity is exempt from tsxation on Ils activitiès because all its income is applied for chantsble purposes.
13-

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS ICONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
14 Tanglble flxed assets
Inls C•ithloann Puffin Lodge Flxturts and
Hou50,
Carnvan,
fittings
Ennlskillon
Ballycastlt
Computsrs
Total
Cogt
At 1 March 2024
Additions
61,199
3,873
6,136
3,227
68,299
332,862
326.726
At 28 February 2025
326.726
61,199
10.009
3,227
401,161
Deproclatlon and Impaimignt
At 1 March 2024
Depreciation charged in the year
8,874
5,232
1,250
881
928
807
11,052
11,253
4,333
At 28 February 2025
4.333
14,106
2.131
1,735
22.305
Carrylng amount
At 28 February 2025
322,393
47,093
7,878
7,492
378,856
At 29 February 2024
52,325
2,623
2,299
57,247
15 Debtors
2025
2024
Amounts falllng due t*4lthin ono year:
Trade debtors
Prepayments and a￿rUed income
120
9,300
9,420
16 Creditors: amounts falling due wlthln on• yoar
2025
2024
Accruals and deferred income
1,620
17 Rostrlctgd fundg
The r6strict8d funds of the charf(y comprise the unexpended balaneAS of donations and grants held on trust
subject to specific condity'ons by donors as to how they may be used.
At 1 March
2024
Incomlng
At28
resources Febfuary 202S
129,260
70,000
199,260
14-

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUAR Y 2025
17 Ro$trlctod funds
{Continued)
Prevlou8 yoar:
At 1 Mar¢h
2023
In¢omlng
At29
resources Fgbfuary 2024
129.260
129.260
18 Unr8strl¢tsd funds
The unrestricted fvnds of the charity comprise the unexpended bolan¢es of donations and grants which are
not subject to specific conditions by donofs and grantots as to how they may be u5&Y. These include
designated funds which have been set aside out of unrestricted fund5 by the trustees for specific purposes.
At 1 March
2024
Incoming
resources
Resources
At28
expended February 2025
General fvnds
221,746
14S,003
{73,5T71
293,172
Previou¥ ygar".
At 1 Mareh
2023
Incoming
r•$our¢9S
Resources
At29
gxpendgd February 2024
General funds
101.623
150,268
{30, 1451
221,746
19 Analysls of net assèts bètwèen funds
Unrèstrietèd
funds
2025
Ro$trl¢t•d
fund$
2025
Total
2025
At 28 February 2025:
Tangible assets
Current assetsllliabilths)
179.596
113,576
199,260
378,856
113,576
293,172
199,260
492.432
Unrestrlcted
fvnds
2024
Re$trlcted
funds
2024
Total
2024
At 29 Febntary 2024:
Tangible assets
Current assetsllliabilitiesl
57,247
184,499
57.247
293,759
129,260
221,746
129,260
351,006
15-

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUAR Y 2025
20 Related party tran6actlons
There.were no disclosable related paty transadtons during the yoar12024- none).
16-